ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
10,1,Calculus urethral,Urinary tract lithiasis NEC,Urolithiases,Renal,N
11,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
13,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
14,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
14,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
14,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
14,4,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
15,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
16,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
16,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
17,1,Headache,Headaches NEC,Headaches,Nerv,N
18,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
19,1,Congenital hypothyroidism,Thyroid disorders congenital,Endocrine disorders congenital,Cong,N
20,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
21,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
23,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
24,1,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
25,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
26,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
27,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
28,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
28,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
30,1,Foetal disorder,Foetal complications NEC,Foetal complications,Preg,N
31,1,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
31,2,Vitamin A deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
32,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
32,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
32,4,Headache,Headaches NEC,Headaches,Nerv,N
32,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
32,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
32,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
32,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
32,9,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
32,10,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
34,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
34,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
38,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
38,2,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
39,1,Migraine,Migraine headaches,Headaches,Nerv,N
40,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
42,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
44,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
45,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
45,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
47,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
48,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
49,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
50,1,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
51,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
52,1,Headache,Headaches NEC,Headaches,Nerv,N
52,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
53,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
56,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,3,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
57,1,Xerophthalmia,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
58,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
58,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
58,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
59,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
60,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
61,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
62,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
63,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
63,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
64,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
65,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
66,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
66,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
67,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
68,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
69,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
71,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Migraine,Migraine headaches,Headaches,Nerv,N
73,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
75,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
76,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
76,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
77,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
78,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
79,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
79,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
80,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
81,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
81,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
83,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
83,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
83,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
83,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
85,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
86,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
87,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
90,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
91,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
93,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
94,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
94,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
96,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
97,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
98,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
99,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
100,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,2,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
100,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
101,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
102,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
102,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
103,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
104,1,Enamel anomaly,Dental surface disorders,Dental and gingival conditions,Gastr,N
105,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
106,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
106,2,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
106,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
107,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
107,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
108,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
109,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
110,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,1,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
113,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
114,1,Acidosis hyperchloraemic,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
115,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
116,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
117,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
118,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
118,2,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
119,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
119,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
119,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
119,4,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
119,5,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
121,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
121,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
122,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
122,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
123,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
123,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
123,3,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
124,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
126,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
127,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
128,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
128,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
129,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
129,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
129,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
129,4,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
130,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
131,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
131,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
133,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
134,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
136,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
137,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
137,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
139,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
139,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
140,1,Hyperchloraemia,Chloride imbalance,Electrolyte and fluid balance conditions,Metab,N
140,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
140,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
141,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
142,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
142,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
142,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
142,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
142,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
142,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
143,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
144,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
144,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
145,1,Acidosis hyperchloraemic,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
146,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
147,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
147,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
147,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
147,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
148,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
148,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
149,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
150,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
151,1,Carcinoid tumour of the small bowel,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
151,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
152,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
152,2,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
153,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
153,2,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
154,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
154,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
155,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
155,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
156,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
156,2,Headache,Headaches NEC,Headaches,Nerv,N
157,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
157,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
157,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
158,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
158,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
159,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
159,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
159,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
159,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
159,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
160,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
161,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
162,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
163,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
164,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
164,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
165,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
166,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
166,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
167,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
167,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
167,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
168,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
169,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
169,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
170,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
170,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,3,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
170,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
170,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
171,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
172,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
172,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
173,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
173,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
174,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
174,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
174,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
175,1,Acidosis hyperchloraemic,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
175,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
175,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
176,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
176,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
176,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
176,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
176,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
176,6,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
176,7,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
176,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
176,9,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
176,10,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
176,11,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
176,12,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
176,13,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
176,14,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
176,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
176,16,Gingival abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
176,17,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
176,18,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
176,19,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
176,20,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
176,21,Hypovitaminosis,Vitamin deficiencies NEC,Vitamin related disorders,Metab,N
176,22,Myalgia,Muscle pains,Muscle disorders,Musc,N
176,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,24,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
176,25,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
176,26,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
176,27,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
177,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
177,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
178,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
178,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
178,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
178,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
179,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
179,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
180,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
180,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
180,3,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
180,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
181,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
181,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,3,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
181,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
182,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
182,2,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
183,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
183,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
184,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
184,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
185,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
185,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
185,3,Headache,Headaches NEC,Headaches,Nerv,N
185,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
185,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
185,6,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
186,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
186,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
186,4,Foreign body,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
186,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
187,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
187,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
187,4,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
187,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
188,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
188,2,Migraine,Migraine headaches,Headaches,Nerv,N
189,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
189,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
189,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
189,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
189,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
190,1,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
191,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
191,2,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
192,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
192,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
192,4,Radiation injury,Radiation injuries,Injuries by physical agents,Inj&P,N
193,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
194,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
194,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
194,4,Radiation injury,Radiation injuries,Injuries by physical agents,Inj&P,N
195,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
195,2,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
195,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
195,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
195,5,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
195,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
195,7,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
195,8,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
195,9,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
195,10,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
196,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
196,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
196,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
196,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
196,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
197,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
197,3,Headache,Headaches NEC,Headaches,Nerv,N
198,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
199,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
199,2,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
200,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
200,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
200,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
200,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
200,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
201,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
201,2,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
202,1,Respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
203,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
203,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
204,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
204,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
205,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
205,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
205,3,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
205,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
205,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
205,6,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
205,7,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
206,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
206,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
206,3,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
206,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
206,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
206,6,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
206,7,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
206,8,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
206,9,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
207,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
209,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
209,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
209,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
210,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
210,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
210,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
211,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
211,2,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
212,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
212,2,Haemorrhagic disease of newborn,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
212,3,Vitamin A deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
212,4,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
213,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
213,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
213,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
213,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
213,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
214,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
214,2,Vitamin A deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
214,3,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
215,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
216,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
216,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
216,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
217,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
217,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
217,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
218,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
219,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
220,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
221,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
221,2,Headache,Headaches NEC,Headaches,Nerv,N
222,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
222,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
222,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
222,4,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
223,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
226,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
226,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
226,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
227,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
227,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
228,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
229,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,4,Multi-vitamin deficiency,Vitamin deficiencies NEC,Vitamin related disorders,Metab,N
230,1,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
231,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
231,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
231,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
232,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
233,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
234,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
234,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
235,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
236,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
236,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
236,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
236,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
236,5,Lack of spontaneous speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
236,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
237,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
237,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
237,3,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
238,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
239,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
240,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
240,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
243,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,2,Drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
243,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
243,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
243,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
244,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
244,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
245,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
245,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
246,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
246,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
247,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
248,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
249,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
249,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
250,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
250,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,4,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
251,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
253,1,Headache,Headaches NEC,Headaches,Nerv,N
253,2,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
253,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
253,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
254,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
254,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
254,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
254,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
254,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
254,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
255,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
